Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Melanoma × Tiragolumab × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Dermatologic 1

Conditions

Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor, Adult 1 Melanoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Breast Neoplasms 1 Advanced Liver Cancers 1

Interventions

pembrolizumab 50 Nivolumab 49 Ipilimumab 27 Cyclophosphamide 15 Specimen Handling 10 Radiosurgery 10 Magnetic Resonance Spectroscopy 10 fludarabine 9 Opdualag 9 Biopsy 8 relatlimab 7 binimetinib 7 aldesleukin 7 Interleukin-2 7 Blood Specimen Collection 7 encorafenib 5 cemiplimab 5 Paclitaxel 5 Immunotherapy 5 Bevacizumab 5 toripalimab 4 atezolizumab 4 Temozolomide 4 CTLA-4 Antigen 4 trametinib 3 spartalizumab 3 lifileucel 3 fludarabine phosphate 3 dabrafenib 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05483400 2025-03-30

TIRACAN

University Medical Center Groningen

Phase 2 Recruiting

DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡